InsiderTrades.com logo
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
From Paradigm Press   |   Ad
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Click here to find out that this 8,788% cryptocurrency is.

BVX Insider Trading

Insider Ownership Percentage: 36.65%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

BiVictriX Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at BiVictriX Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BiVictriX Therapeutics Share Price & Price History

Current Price: GBX 11.50
Price Change: +0.30 (1.20%)
As of 04/24/2024 10:20 PM ET

This chart shows the closing price history over time for BVX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Bitcoin Rockets To Record High But Buy THIS Instead
From Paradigm Press   |   Ad
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
>>Click here to find out what it is.

BiVictriX Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2022Iain Gladstone RossInsiderBuy30,000GBX 18£5,400
3/8/2022Iain Gladstone RossInsiderBuy100,000GBX 22£22,000
12/20/2021Tiffany Jane ThornInsiderBuy25,000GBX 26£6,500
11/4/2021Robert Edward HawkinsInsiderBuy20,000GBX 22£4,400
9/22/2021Iain Gladstone RossInsiderBuy43,507GBX 19£8,266.33
See Full Table
Global crypto currency reset (41 major banks signed up)
From Stansberry Research   |   Ad
Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...
 Here's everything you need to know.

SEC Filings (Institutional Ownership Changes) for BiVictriX Therapeutics (LON:BVX)

34.76% of BiVictriX Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

BiVictriX Therapeutics logo
BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia, as well as develops BVX002 and BVX003 for various blood cancers and solid tumours. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.
Read More on BiVictriX Therapeutics

Today's Range

Now: GBX 11.50
Low: 11.50
High: 11.50

50 Day Range

MA: GBX 11.44
Low: 10.51
High: 12

52 Week Range

Now: GBX 11.50
Low: 9
High: 16

Volume

428 shs

Average Volume

59,389 shs

Market Capitalization

£9.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of BiVictriX Therapeutics?

BiVictriX Therapeutics' top insider shareholders include:
  1. Iain Gladstone Ross (Insider)
Learn More about top insider investors at BiVictriX Therapeutics.
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
From Paradigm Press   |   Ad
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Click here to find out that this 8,788% cryptocurrency is.